Working to Eradicate Gynecologic Cancers

Ramez N. Eskander, MD

Gynecologic Oncologist
University of California at Irvine Medical Center
101 The City Drive, South
Building 56, Room 260
Orange, CA
USA 92868


Biographical Sketch:
2012: Exxcellence Foundation, Philip J DiSaia Research grant award recipient 2012: Queen of Hearts Research Award Recipient Eskander, R N, Sakai T, Guo Y, Randall L, Hoang B, Zi X. Flavokawain B, a novel chalcone, exhibits robust apoptotic effects and indices G2/M arrest of a uterine leiomyosarcoma cell line; Journal of Obstetrics and Gynecology Research 2012; PMID: 22540374. My laboratory and clinical research projects have resulted in 10 peer-reviewed publications in less than 24 months"

Papers:
67 - Featured Poster Short-term morbidity and mortality associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent/advanced-stage ovarian cancer 107 - Scientific Plenary Hospital readmission (30-day) following surgery for advanced-stage ovarian cancer: analysis of risk factors and cost using the SEER-Medicare database 129 - Featured Poster Assessment of palliative care training in gynecologic oncology: a Gynecologic Oncology Fellows Research Network study 186 - Poster Session A Gynecologic oncology fellow perspectives on research and career development symposia: a Gynecologic Oncology Fellows' and Allied Health Professionals' Research Network (GOFRN) survey study GOFRN: The Fellows' Perspective